| Simulation-Based Optimization of Sampling Schedules for Model-Informed Precision Dosing of Once-Daily and 4-Times-Daily Busulfan in Pediatric Patients | Therapeutic drug monitoring |  | | 2024 | 17 | 99 |
|
| Implementing pharmacogenetic testing to optimize proton-pump inhibitors use among Indian population based on CPIC-CYP2C19-PPI dosing guidelines : The need of the hour | Indian Journal of Pharmacology |  | | 2024 | 15 | 449 |
|
| The Role of Genomics in Reshaping Healthcare Delivery : Personalized Medicine | The National Medical Journal of India |  | | 2024 | 20 | 86 |
|
| Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta-Blocker Therapy | Clinical pharmacology and therapeutics |  | | 2024 | 21 | 1,054 |
|
| In vitro screening of UGT2B10 in silico prioritized putative ligands from drugs used in the pediatric hematopoietic stem cell transplantation setting | Pharmacology research & perspectives |  | | 2024 | 101 | 155 |
|
| A review of real-world evidence on preemptive pharmacogenomic testing for preventing adverse drug reactions : a reality for future health care | Pharmacogenomics journal |  | | 2024 | 73 | 191 |
|
| Impact of Genetic Variants on Postoperative Pain and Fentanyl Dose Requirement in Patients Undergoing Major Breast Surgery: A Candidate Gene Association Study | Anesthesia and analgesia |  | | 2023 | 76 | 0 |
|
| Impact of pharmacogenomics in achieving personalized/precision medicine in the clinical setting: a symposium report | Pharmacogenomics |  | | 2023 | 62 | 173 |
|
| Clinical Pharmacology and Pharmacogenomics for Implementation of Personalized Medicine | Pharmacogenomics |  | | 2023 | 29 | 424 |
|
| Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with Busulfan | Bone marrow transplantation |  | | 2023 | 15 | 85 |
|
| Pharmacokinetic Modeling and Simulation with Pharmacogenetic Insights Support the Relevance of Therapeutic Drug Monitoring for Myeloablative Busulfan Dosing in Adult HSCT | Transplantation and cellular therapy |  | | 2023 | 94 | 152 |
|
| Role of Drug Transporters in Elucidating Inter-Individual Variability in Pediatric Chemotherapy-Related Toxicities and Response | Pharmaceuticals |  | | 2022 | 87 | 36 |
|
| A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation | BMC molecular and cell biology |  | | 2022 | 80 | 289 |
|
| Cohort-based association study of germline genetic variants with acute and chronic health complications of childhood cancer and its treatment: Genetic Risks for Childhood Cancer Complications Switzerland (GECCOS) study protocol | BMJ open |  | | 2022 | 74 | 109 |
|
| Prioritization of microRNA biomarkers for a prospective evaluation in a cohort of myocardial infarction patients based on their mechanistic role using public datasets | Frontiers in cardiovascular medicine |  | | 2022 | 103 | 222 |
|
| GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation | Journal of cancer research and clinical oncology |  | | 2022 | 395 | 212 |
|
| Genetic susceptibility to acute graft versus host disease in pediatric patients undergoing HSCT | Bone marrow transplantation |  | | 2021 | 283 | 2 |
|
| Excellent overall and chronic graft-versus-host-disease-free event-free survival in Fanconi anaemia patients undergoing matched related- and unrelated-donor bone marrow transplantation using alemtuzumab-Flu-Cy: the UK experience | British journal of haematology |  | | 2021 | 238 | 0 |
|
| Indo-Swiss symposium on advances in pharmacogenomic strategies for implementation of personalized medicine | Pharmacogenomics |  | | 2021 | 287 | 0 |
|
| Pediatric Therapeutic Drug Monitoring for Selective Serotonin Reuptake Inhibitors | Frontiers in pharmacology |  | | 2021 | 82 | 819 |
|
| Impact of computerised physician order entry (CPOE) on the incidence of chemotherapy-related medication errors: a systematic review | European journal of clinical pharmacology |  | | 2021 | 320 | 332 |
|
| The Catalytic Activity of GSTM1 In vitro is Independent of MAPK8 | Drug metabolism letters |  | | 2021 | 107 | 113 |
|
| In silico and in vitro investigations on the protein–protein interactions of glutathione S-transferases with mitogen-activated protein kinase 8 and apoptosis signal-regulating kinase 1 | Journal of Biomolecular Structure and Dynamics |  | | 2021 | 303 | 258 |
|
| Precision dosing of intravenous busulfan in pediatric hematopoietic stem cell transplantation: Results from a multicenter population pharmacokinetic study | CPT: pharmacometrics & systems pharmacology |  | | 2021 | 250 | 245 |
|
| Spectrophotometric Screening for Potential Inhibitors of Cytosolic Glutathione S-Transferases | Journal of Visualized Experiments |  | | 2020 | 364 | 1,179 |
|
| Genetic Susceptibility to Hepatic Sinusoidal Obstruction Syndrome in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation | Biology of Blood and Marrow Transplantation |  | | 2020 | 348 | 0 |
|
| Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing | Clinical Pharmacology and Therapeutics |  | | 2020 | 297 | 0 |
|
| Comparing Dried Blood Spots and Plasma Concentrations for Busulfan Therapeutic Drug Monitoring in Children | Therapeutic Drug Monitoring |  | | 2020 | 456 | 247 |
|
| Association of NUDT15*3 and FPGS 2572C>T Variants with the Risk of Early Hematologic Toxicity During 6-MP and Low-Dose Methotrexate-Based Maintenance Therapy in Indian Patients with Acute Lymphoblastic Leukemia | Genes |  | | 2020 | 263 | 226 |
|
| Neuroprotective agents in Acute Ischemic Stroke-A Reality Check | Biomedicine & Pharmacotherapy |  | | 2019 | 288 | 526 |
|
| Incorporation of GSTA1 genetic variations into a population pharmacokinetic model for IV busulfan in paediatric hematopoietic stem cell transplantation | British Journal of Clinical Pharmacology |  | | 2018 | 380 | 244 |
|
| Association of CTH variant with sinusoidal obstruction syndrome in children receiving intravenous busulfan and cyclophosphamide before hematopoietic stem cell transplantation | The Pharmacogenomics Journal |  | | 2018 | 529 | 292 |
|
| Frequency of chemotherapy medication errors: A systematic review | Journal of Pharmacology and Pharmacotherapeutics |  | | 2018 | 674 | 577 |
|
| Development and validation of an allele-specific PCR assay for genotyping a promoter and exonic single nucleotide polymorphisms of MGMT gene | Journal of Biological Methods |  | | 2018 | 324 | 169 |
|
| Developmental Pattern of Hepatic Drug‑Metabolizing Enzymes in Pediatric Population and its Role in Optimal Drug Treatment | Archives of Medicine and Health Sciences |  | | 2017 | 372 | 1,317 |
|
| GSTA1 Genetic Variants and Conditioning Regimen: Missing Key Factors in Dosing Guidelines of Busulfan in Pediatric Hematopoietic Stem Cell Transplantation | Biology of Blood and Marrow Transplantation |  | | 2017 | 503 | 17 |
|
| GSTA1 diplotypes affect busulfan clearance and toxicity in children undergoing allogeneic hematopoietic stem cell transplantation: a multicenter study | Oncotarget |  | | 2017 | 562 | 341 |
|
| Potential Predictive Biomarkers used to optimize treatments for Sinusoidal Obstruction Syndrome in pediatric Hematopoietic stem cell transplantation | Bulletin suisse du cancer |  | | 2016 | 455 | 1,799 |
|
| Commentary: A myriad aberrations on information of ontogeny of drug metabolizing enzymes in the pediatric population: an obstacle for personalizing drug therapy in the pediatric population | Drug metabolism letters |  | | 2016 | 595 | 393 |
|
| Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition--The Dream of Translational Medicine | Journal of Cardiovascular Pharmacology |  | | 2016 | 463 | 0 |
|
| Detection of busulfan adducts on proteins | RCM. Rapid communications in mass spectrometry |  | | 2016 | 678 | 412 |
|
| Pharmacogenomics in Pediatric Oncology: Review of Gene-Drug Associations for Clinical Use | International Journal of Molecular Sciences |  | | 2016 | 589 | 635 |
|
| Severe Vincristine-Induced Neuropathic Pain in a CYP3A5 Nonexpressor With Reduced CYP3A4/5 Activity: Case Study | Clinical therapeutics |  | | 2016 | 560 | 2 |
|
| The association of cytochrome P450 genetic polymorphisms with sulfolane formation and the efficacy of a busulfan-based conditioning regimen in pediatric patients undergoing hematopoietic stem cell transplantation | Pharmacogenomics journal |  | | 2014 | 744 | 8 |
|
| Pharmacogenetic aspects of drug metabolizing enzymes in busulfan based conditioning prior to allogenic hematopoietic stem cell transplantation in children | Current drug metabolism |  | | 2014 | 548 | 9 |
|
| The clinical relevance of pre-formed anti-HLA and anti-MICA antibodies after cord blood transplantation in children | PloS one |  | | 2013 | 731 | 434 |
|
| Validation of SYBR Green based quantification assay for the detection of human Torque Teno virus titers from plasma | Virology journal |  | | 2013 | 663 | 243 |
|
| Glutathione S-transferase gene variations influence BU pharmacokinetics and outcome of hematopoietic SCT in pediatric patients | Bone marrow transplantation |  | | 2013 | 664 | 5 |
|
| Transcriptional regulation of CYP2C19 and its role in altered enzyme activity | Current drug metabolism |  | | 2012 | 614 | 0 |
|
| A novel method for quantification of sulfolane (a metabolite of busulfan) in plasma by gas chromatography-tandem mass spectrometry | Analytical & bioanalytical chemistry |  | | 2012 | 669 | 376 |
|
| A simplified method for busulfan monitoring using dried blood spot in combination with liquid chromatography/tandem mass spectrometry | RCM. Rapid communications in mass spectrometry |  | | 2012 | 851 | 969 |
|
| Influence of age, sex, and haplotypes of thiopurine methyltransferase (TPMT) gene on 6- mercaptopurine toxicity in children with acute lymphoblastic leukemia | European journal of clinical pharmacology |  | | 2012 | 608 | 336 |
|